Page 3 - Pharma India News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma india. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma India Today - Breaking & Trending Today

Waiver for rare disease drugs brings little relief: Pharma sector

India s pharma sector on Wednesday said the Goods and Services Tax (GST) Council s decision to exempt tax on rare diseases drugs is unlikely to benefit the population unless the waiver is extended to drugs that are made commercially available in the country.

The GST Council on Tuesday (July 11) said the Integrated Goods and Services Tax (IGST) on medicines and Food for Special Medical Purposes (FSMP) used for treating rare diseases enlisted under the National Policy for Rare Diseases, 2021, will be exempt when imported for personal use subject to existing conditions.

We support the government s move to address the needs of patients suffering from rare diseases. ....

Simpson Emmanuel , Suresh Pattathil , National Policy For Rare Diseases , Organisation Of Pharmaceutical Producers India , Services Tax , Council On Tuesday , Integrated Goods , Special Medical Purposes , National Policy , Rare Diseases , Rare Disease , Pharma India , Pharmaceutical Producers , Basic Custom Duty , Business News , Usiness News India , Ndia Business News , Ndian Economy News , Ndian Financial News ,

How Dilip Shanghvi scripted a dramatic turnaround for Sun Pharma

Cut to 2023. In FY23, Sun Pharma registered its highest-ever consolidated revenue of Rs 43,279 crore and net profit of Rs 8,474 crore, signalling to the market that the company was back in the game. - Issue Date: Jul 23, 2023 ....

Binu Paul , Sun Pharma , Neetu Chandra Sharma , Dilip Shanghvi , Sun Pharmaceutical Industries Ltd , Ranbaxy Laboratories , Sun Pharmaceutical Industries , Dilip Shanghvi , Pharma Business , Indian Pharma , Pharma India , Un Pharmaceuticals Issue Date Jul 23 ,

Suzlon Energy, Uno Minda, Astrazeneca Pharma form Doji. What does this tell about stocks?

Three Indian stocks, Suzlon Energy, Uno Minda, and Astrazeneca Pharma India, have formed Doji or Near Doji candlestick patterns, indicating market indecision and a potential reversal or continuation of trends. Candlestick patterns, widely used by technical analysts to identify potential trading signals, convey significant market sentiment. Investors should closely monitor subsequent price action to validate the pattern s significance and exercise caution before making investment decisions. ....

Uno Minda , Astrazeneca Pharma India Ltd , Suzlon Energy , Minda Ltd , Suzlon Energy Ltd , Astrazeneca Pharma India , Near Doji , Doji Candlestick Pattern , Pharma India ,